查看本页中文译文 >>
View a Chinese translation of this page >>

Instructions for authors


Editorial policies

BMJ Open is an open access journal dedicated exclusively to publishing medical research. The journal aims to provide rapid publication of research across a range of medical disciplines and therapeutic areas, through a continuous publication model. As well as publishing definitive articles, including small and specialist studies, BMJ Open will consider protocols and pilot studies. See here for more information on what we publish.

Submissions should be made through our online submission system. Submissions will only be published after peer review, and reviewers' comments will be published alongside accepted manuscripts.

Articles should not be under review, or submitted for review, with any other journal when submitted to BMJ Open. This includes other journals from BMJ.

Authors retain copyright; articles are published under a Creative Commons licence.

Open access
Authors retain copyright of their work. Articles are published under Creative Commons licences, including licences that meet RCUK and Wellcome Trust requirements. Our full licence is here.

Article publishing charges
BMJ Open levies an article publishing charge that reflects the true cost of the services provided. The charge (exclusive of VAT for UK and EU authors) is £1350. Charges for publishing a study protocol are 50% of the research article charge; a 50% discount will then also be available to the protocol's authors to publish the subsequent research findings in the journal, provided the results are submitted within a reasonable time from completion of the research. There are no submission or page charges, and no colour charges. Unless a waiver has been granted, accepted articles will not be published until payment has been received.

Your institution may already have arranged to cover your publishing costs or you may be eligible for a discount. Click here to find out.

Publishing in BMJ Open enables you to fulfil the open access requirements of the Wellcome Trust and Research Councils UK, including using their preferred CC BY licence.

Articles are published online approximately 30 days from processing to production. BMJ are unable to process cancellations, refunds or returns for open access charges.

Waivers and discounts
We appreciate that some authors do not have access to funding to cover publication costs. The journal will accept part payment where only limited funds are available, and offers a waiver to authors unable to pay on request. No payment information is requested before an article is accepted, so the ability to pay cannot affect editorial decisions. BMJ Open offers a 100% waiver to corresponding authors from institutions based in Hinari Band 1 countries, and a 50% waiver to authors from institutions based in Hinari Band 2 countries. In recognition of reviewers' support, any reviewer that returns a full review, on time, can receive a 25% discount on article publishing charges for a paper for which they are the corresponding author, if submitted within 12 months of completing the review.

Studies that are wholly or part funded by the tobacco industry

BMJ Open will not consider for publication any study partly or wholly funded by the tobacco industry, as explained here.

Submission policies

For guidelines on policy and submission across our journals, please click on the links below:

Manuscript preparation
Editorial policies
Patient consent forms
Licence forms
Peer review
Submission and production processes

Please note that in some cases BMJ Open has different submission requirements (e.g. there are no colour charges); where this is the case these are outlined below.

Article types

Research articles
All articles should include the following.

  • The article title should include the study type.
  • A structured abstract (max. 300 words) including the following (please note that for RCTs there is a specific CONSORT extension for abstracts):
    • objectives: clear statement of main study aim and major hypothesis/research question
    • design: e.g. prospective, randomised, blinded, case control
    • setting: level of care e.g. primary, secondary; number of participating centres. Generalise; don't use the name of a specific centre, but give geographical location if important
    • participants: numbers entering and completing the study; sex and ethnic group if appropriate. Clear definitions of selection, entry and exclusion criteria
    • interventions: what, how, when and how long (this can be deleted if there were no interventions)
    • primary and secondary outcome measures: planned (i.e. in the protocol) and those finally measured (if different, explain why) - for quantitative studies only
    • results: main results with (for quantitative studies) 95% confidence intervals and, where appropriate, the exact level of statistical significance and the number need to treat/harm. Whenever possible, state absolute rather than relative risks
    • conclusions: primary conclusions and their implications, suggest areas for further research if appropriate. Do not go beyond the data in the article
    • where applicable, trial registration: registry and number (for clinical trials and, if available, for observational studies and systematic reviews)
  • An 'Article summary' section consisting of the heading: 'Strengths and limitations of this study', and containing up to five bullet points that relate specifically to the study reported. This should be placed after the abstract.
  • The original protocol for the study, where one exists as a supplementary file.
  • A funding statement, preferably worded as follows. Either: 'This work was supported by [name of funder] grant number [xxx]' or 'This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors'. You must ensure that the full, correct details of your funder(s) and any relevant grant numbers are included.
  • A competing interests statement. See this advice from the BMJ on what to include.
  • Articles should list each author's contribution individually at the end; this section may also include contributors who do not qualify as authors.
  • Any checklist and flow diagram for the appropriate reporting statement, e.g. STROBE (see below).
  • Any article that contains personal medical information about an identifiable living individual requires the patient's explicit consent before we can publish it. We will need the patient to sign our consent form, which requires the patient to have read the article. This form is available in multiple languages.
  • Please provide a data sharing statement such as: "Technical appendix, statistical code, and dataset available from the corresponding author at Dryad repository, who will provide a permanent, citable and open access home for the dataset.


We recommend your article does not exceed 4000 words, with up to five figures and tables. This is flexible, but exceeding this will impact upon the paper's 'readability'. Supplementary and raw data can be placed online alongside the article, and we may request that you separate out some material into supplementary data files to make the main manuscript clearer for readers.

We also recommend, but do not insist, that the discussion section is no longer than five paragraphs and follows this overall structure (you do not need to use these as subheadings): a statement of the principal findings; strengths and weaknesses of the study; strengths and weaknesses in relation to other studies, discussing important differences in results; the meaning of the study: possible explanations and implications for clinicians and policymakers; and unanswered questions and future research.

Authors are encouraged to submit figures and images in colour - there are no colour charges.

At upload you will be asked to choose one general subject area that applies to your article - it will be published under this banner on the main table of contents. You will also be asked to select further subject headings to be used for the 'Browse by topic' section, and specific keywords for help with identifying reviewers.

Reporting guidelines
The guidelines listed below should be followed where appropriate. Please use these guidelines to structure your article. Completed applicable checklists, structured abstracts and flow diagrams should be uploaded with your submission; these will be published alongside the final version of your paper.

The Equator Network (Enhancing the Quality and Transparency Of health Research) provides a comprehensive list of reporting guidelines.

Data sharing
See also our data sharing FAQs.

Study protocols

Protocol manuscripts should report planned or ongoing studies. If data collection is complete, we will not consider the manuscript.

Publishing study protocols enables researchers and funding bodies to stay up to date in their fields by providing exposure to research activity that may not otherwise be widely publicised. This can help prevent unnecessary duplication of work and will hopefully enable collaboration. Publishing protocols in full also makes available more information than is currently required by trial registries and increases transparency, making it easier for others (editors, reviewers and readers) to see and understand any deviations from the protocol that occur during the conduct of the study.

The SPIRIT (Standard Protocol Items for Randomized Trials) statement has now been published (see here for details). It is an evidence-based tool developed through systematic review of a wide range of resources and consensus. It closely mirrors the CONSORT statement and also reflects important ethics considerations. We encourage investigators to adhere to the SPIRIT recommendations when drafting their protocols.

Various other resources exist that list the ingredients of an authoritative trial protocol, e.g. the UK Dept of Health/Medical Research Council Clinical Trials Toolkit and the US National Institutes for Health provide advice on how to structure a trial protocol. BMJ Open will consider for publication protocols for any study design, including observational studies and systematic reviews.

We strongly encourage you to register your study. Prospective registration is mandatory for any clinical trials. Acceptable registries for trials are listed here. We recommend Prospero for registration of systematic reviews.

General BMJ policies apply (see above) on manuscript formatting, editorial policies, licence forms and patient consent (where applicable to study designs). Protocols should include, as a minimum, the following items.

  • Protocol papers should report planned or ongoing studies. Manuscripts that report work already carried out will not be considered as protocols.
  • Protocols for studies that will require ethical approval, such as trials, are unlikely to be considered without having received that approval.
  • Title: this should include the specific study type, e.g. randomised controlled trial.
  • Abstract: this should be structured with the following sections. Introduction; Methods and analysis; Ethics and dissemination. Registration details should be included as a final section, if appropriate.
  • Introduction: explain the rationale for the study and what evidence gap it may fill. Appropriate previous literature should be referenced, including relevant systematic reviews.
  • Methods and analysis: provide a full description of the study design, including the following. How the sample will be selected; interventions to be measured; the sample size calculation (drawing on previous literature) with an estimate of how many participants will be needed for the primary outcome to be statistically, clinically and/or politically significant; what outcomes will be measured, when and how; a data analysis plan.
  • Ethics and dissemination: ethical and safety considerations and any dissemination plan (publications, data deposition and curation) should be covered here.
  • Full references.
  • Authors' contributions: state how each author was involved in writing the protocol.
  • Funding statement: preferably worded as follows. Either: 'This work was supported by [name of funder] grant number [xxx]' or 'This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors'.
  • Competing interests statement.

Pilot studies
Articles reporting pilot studies should explain the work's wider context and explain why the term 'pilot study' applies. The term 'pilot study' should not be applied to justify reporting a small-scale study. Justifications for a pilot study include:

  • trialling a new procedure intended for use in a larger programme of research
  • establishing power calculations required for a full-scale study
  • establishing how many patients and/or healthcare professionals can be recruited
  • evaluating the financial, technical, administrative or logistic feasibility of a full-scale study, including issues of data collection, protocol adherence, and questionnaire design.

The sample/patient size should still be justified. The article should explain the impact that the pilot study had on decisions regarding future research.

Rapid responses and online comments
We encourage readers to comment on articles published in BMJ Open. Please follow our guidelines set out in our Blog and eLetter response terms and requirements, available here. It is also possible to post less-formal comments online at the end of articles using the Disqus commenting facility.

Peer review process

All articles published in BMJ Open will have been sent for external, open peer review. Reviewers will not be asked to judge importance or breadth of appeal. Readers will be able to make these judgements for themselves. We recommend you use our instructions for reviewers as a checklist to ensure that your article is complete. Upon publication, all previous versions of the manuscript will also be made available, as will the reviewers' comments and authors' replies to those comments.


Peer review of study protocols
BMJ Open will consider publishing without peer review protocols that have formal ethical approval and funding from a recognised, open access advocating research-funding body (such as those listed by the JULIET project). Please provide proof that these criteria are met when uploading your protocol. Any protocols that do not meet both these criteria will be sent for open external peer review, with reviewer comments published online upon acceptance, as with research articles. Reviewers will be instructed to review for clarity and sufficient detail. The intention of peer review is not to alter the study design. Reviewers will be instructed to check that the study is scientifically credible and ethically sound in its scope and methods, and that there is sufficient detail to instil confidence that the study will be conducted and analysed properly.

As with research articles, protocols will be published under a Creative Commons licence.


The journals from BMJ are willing to consider publishing supplements. Supplement proposals may be made at the request of:

  1. The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
  2. The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
  3. The BMJ itself may have proposals for supplements where sponsorship may be necessary.
  4. A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.

In all cases, it is vital that the journal's integrity, independence and academic reputation is not compromised in any way. All supplements are fully peer-reviewed. For further information on criteria that must be fulfilled, download the supplements guidelines (PDF).

Plagiarism detection

BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting

Don't forget to sign up for content alerts to receive selected information relevant to your specialty interests and be the first to know when the latest research is published.